期刊文献+

术前放化疗结合全直肠系膜切除在低位进展期直肠癌治疗中的应用 被引量:7

Preoperative Concurrent Chemoradiotherapy Combined with Total Mesorectal Excision in Treatment for Locally Advanced Lower Rectal Cancer
原文传递
导出
摘要 目的分析术前放化疗结合全直肠系膜切除术(TME)治疗低位进展期直肠癌的疗效。方法回顾性分析笔者所在医院2009年1月至2011年12月期间行术前放化疗联合TME的31例低位进展期直肠癌患者的临床资料。放疗采用常规分割放疗,总剂量50 Gy/25 f;化疗采用mFOLFOX6或CapeOX方案。临床-病理对照记录疗效,并评价保肛患者的肛门功能。结果全部患者均接受TME手术治疗,手术并发症发生率为12.9%(4/31),死亡率为3.2%(1/31)。经术前放化疗,肿瘤直径平均缩小21.9%;48.4%(15/31)的患者出现T分期下降,阳性淋巴结患者比例由83.9%(26/31)降至38.7%(12/31),5例(16.1%)患者获得病理学完全缓解,总有效率达74.2%(23/31);Ⅲ~Ⅳ度不良反应发生率为6.5%(2/31),保肛患者肛门功能良好率达84.6%(22/26)。结论从本组有限的病例看,对低位进展期直肠癌采用术前放化疗结合TME手术能够达到部分肿瘤的病理学完全缓解,缩小原发肿瘤,降低局部淋巴结转移率,从而达到降低肿瘤分期、提高手术疗效的目的。 Objective To evaluate the efficacy of preoperative concurrent chemoradiotherapy combined with total mesorectal excision(TME)in treatment for locally advanced lower rectal cancer.Methods The clinical data of 31 patients with locally advanced lower rectal cancer received concurrent chemoradiotherapy from January 2009 to December 2011 in this hospital were analyzed retrospectively.Conventional fraction radiotherapy with total dose 50 Gy and chemotherapy with mFOLFOX6 or CapeOX regimen were taken.The efficacy was assessed by recording results of clinical and pathological examination.The function of sphincter was also recorded.Results All 31 patients underwent TME operation.The complication morbidity and mortality was 12.9%(4/31)and 3.2%(1/31),respectively.As a result of the preoperative management,the tumor was reduced by an average of 21.9%,down-regulation of T stage was observed in 48.4%(15/31)patients,the frequency of lymph node metastasis decreased from 83.9%(26/31)to 38.7%(12/31).Pathological complete response was observed in 5 patients(16.1%)and the total response rate was 74.2%(23/31),grade 3/4 toxicity was occurred in 2(6.5%)patients.84.6%(22/26)of patients underwent sphincter preservation surgery reserved good function of sphincter.Conclusions Preoperative concurrent chemoradiotherapy combined with TME in treatment for locally advanced lower rectal cancer is effective and safe,which can lead to pathological complete response,decrease the tumor stage and the rate of lymph node metastasis,and can also increase the efficacy of operation.
出处 《中国普外基础与临床杂志》 CAS 2012年第9期971-974,共4页 Chinese Journal of Bases and Clinics In General Surgery
关键词 直肠痛 术前放化疗 伞盲肠系膜切除 Rectal cancer Preoperative chemoradiotherapy Total mesorectal excision
  • 相关文献

参考文献11

  • 1柴宇啸,曲兴龙,王奕静,韩毓,张怡,王洪林.同步新辅助放化疗联合全直肠系膜切除术治疗中低位局部进展期直肠癌的临床研究[J].肿瘤,2011,31(7):658-661. 被引量:34
  • 2肖毅.直肠癌新辅助治疗[J].中国普外基础与临床杂志,2010,17(9):906-909. 被引量:11
  • 3于波,金伟森,李世拥,梁振家,苑树俊,白雪,左富义.T3期中低位直肠癌同步放化疗后行保肛手术的临床研究[J].结直肠肛门外科,2009,15(4):221-223. 被引量:3
  • 4Tulchinsky H, Shmueli E, Figer A, et al. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer[J]. Ann Surg Oncol, 2008, 15(10):2661-2667.
  • 5Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016):a multicentre, randomised trial[J]. Lancet, 2009, 373(9666):811-820.
  • 6Birgisson H, P?hlman L, Gunnarsson U, et al. Adverse effects of preoperative radiation therapy for rectal cancer:long-term follow-up of the Swedish Rectal Cancer Trial[J]. J Clin Oncol, 2005, 23(34):8697-8705.
  • 7Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer[J]. N Engl J Med, 1997, 336:980-987.
  • 8Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer[J]. Lancet, 1986, 1(8496):1479-1482.
  • 9Williams NS, Patel J, George RD, et al. Development of an electrically stimulated neoanal sphincter[J]. Lancet, 1991, 338(8776):1166-1169.
  • 10Roh MS, Yothers GA, O’Conneu MJ, et al. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum:NSABP R-04 [J]. J Clin Oncol, 2011, 29(Suppl):abstr 3503.

二级参考文献129

  • 1石全,邓晓军,熊春,郑绍光,韦敬以,蒙建强.低位直肠癌术前放化疗与手术治疗效果观察[J].广西医科大学学报,2005,22(6):961-962. 被引量:5
  • 2蔡钢,章真.直肠癌的辅助放化疗的临床研究[J].中国癌症杂志,2006,16(5):399-402. 被引量:13
  • 3Davies M,Harries D,Hirst G,et al.Local recurrence after abdomino-perineal resection[J].Colorectal Dis.2009,11(1):39-43.
  • 4Eriksen MT,Wibe A,Haffner J,et al.Prognostic groups in 1676 patients with T3 rectal cancer treated without preoperative radiotherapy[J].Dis Colon Rectum.2007,50(2):156-167.
  • 5Akasu T,Takawa M,Yamamoto S,et al.Incidence and patterns of recurrence after intersphincteric resection for very low rectal adenocarcinoma[J].J Am Coll Surg.2007,205(5):642-647.
  • 6Chamlou R,Parc Y,Simon T,et al.Long-term results of intersphincteric resection for low rectal cancer[J].Ann Surg.2007,246(6):916-921.
  • 7Richard CS,Phang PT,McLeod RS,et al.Canadian Association of General Surgeons Evidence Based Reviews in Surgery.5.Need for preoperative radiation in rectal cancer.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer[J].Can J Surg.2003,46(1):54-56.
  • 8Kapiteijn E,Marijnen CA,Nagtegaal ID,et al.Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer[J].N Engl J Med.2001,345(9):638-646.
  • 9Peeters KC,Marijnen CA,Nagtegaal ID,et al.The TME trial after a median follow-up of 6 years:increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma[J].Ann Surg.2007,246(5):693-701.
  • 10Gosens MJ,Dresen RC,Rutten HJ,et al.Preoperative radiochemotherapy is successful also in patients with locally advanced rectal cancer who have intrinsically high apoptotic tumours[J].Ann Oncol.2008,19(12):2026-2032.

共引文献58

同被引文献68

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部